Study Group: Pathologists (US)(?)
Council Members in this Study Group: 824
Request a survey with this Study Group
Leading Experts in this Study Group
Medical Director
Icon Central Laboratories, Inc.
Joseph Schappert, MD, is the Medical Director at ICON Laboratories, Inc. in New York. He is involved in innovative and state-of-art information technology, flow cytometric and molecular diagnostic solutions in support of clinical trials conducted worldwide. Previously, Dr. Schappert was the Vice Chair...
Director of Pathology
Bellevue Hospital Center
Robert Boorstein, MD, PhD, is the Director of Pathology at Bellevue Hospital and an Associate Professor in the Department of Pathology at New York University School of Medicine. He is also the Medical Director for Pathology and Laboratory Medicine of the South Manhattan Healthcare Network and Northern...
Founder and Senior Pathologist
Chestatee Pathology Associates, PC
John Cochran, MD, is the Chief Executive Officer of Chestatee Pathology Associates, PC (Atlanta, GA). He is the Medical Director of two Atlanta-area hospital laboratories. Dr. Cochran has consulted on the following companies: Genzyme, ePocrates, Cerner, NextGen, AllScripts, GE Healthcare, Immucor, Beckman...
Transfusion Service Director
Hennepin County Medical Center
Jed Gorlin, MD, MBA, is the Medical Director of the Memorial Blood Center of Minnesota and an Associate Professor of Laboratory Medicine and Pediatrics at the University of Minnesota. Dr. Gorlin is also the Transfusion Services Director at Hennepin County Medical Center. His research includes the hematopoietic...
Assistant Clinical Professor of Medicine
New York- Presbyterian/Columbia University Medical Center
Jin Suh, MD, is an Assistant Clinical Professor of Medicine at the Columbia University College of Physicians and Surgeons. He is also an Associate Medical Director of the HIV-AIDS Program at St. Luke's-Roosevelt Hospital, New York. Dr. Suh is board certified in Internal Medicine and Infectious Disease....
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
TODAY MANY PATIENTS HAS DILEMA TO BUY FOOD OR DRUG EFECTIVENESS OF GENERIC DRUG ALSO MAIL ORDER OR LOCAL PHARMACY COST
Diagnostic tools are availible to identify these adverse effects at an early stage in their clinical development. These tools should mitigate the seriousness of these adverse events.
1) Dissemination of information on Botox related complications is important. 2) Lay press coverage of Botox related complications will likely transiently reduce Botox utilization. 3) A "black box" warning from the FDA will serve no useful purpose.
Integrating conventional blood analysis with flow cytometry paves the way for penetration from the former routine testing market into the latter, specialized cancer testing market. This platform has the potential to broaden penetration by offering more test capabilities onto an existing platform....
The holy grail of pharmacology is specificity, inventing drugs that faithfully reach their target but do not affect other cells. Monoclonal antibodies have potential but have not yet reached that mark. Monoclonal T cell receptors (mTCR) might succeed where all other drugs have failed.
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Academic Institution*
- Lab, Academic Medical Center
- Laboratory, Independent
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Lab, Non-Academic/Community Hospital
Most Common Job Types:
- Physician - Attending Physician
- Director
- Professor
- Physician - Director
- Research Scientist
- Physician - Department Chair
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms